Papaconstantinou H T, Bullard K M, Rothenberger D A, Madoff R D
Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Colorectal Dis. 2006 Feb;8(2):124-9. doi: 10.1111/j.1463-1318.2005.00911.x.
Chemotherapy and radiation (C-XRT) is the first-line therapy for epidermoid carcinomas of the anal canal (ECAC). Treatment failure occurs in up to 33% of patients. Salvage-abdominoperineal resection (APR) is the treatment of choice for locoregional failure but pre-operative radiation may increase wound complications. The purpose of this study was to evaluate patient survival and wound complications after salvage-APR for C-XRT failure.
We reviewed the clinical records of all patients who failed initial C-XRT for ECAC diagnosed between 1992 and 2002. We evaluated patient demographics, treatment, tumour characteristics, survival and postoperative complications.
Nineteen patients were identified. The mean age at diagnosis was 55 years. Eight (42%) patients had persistent disease; 11 (58%) had tumour recurrence. APR was performed in 15 patients. Perineal wound complications occurred in 12 (80%) patients; half were major complications. Primary flap reconstruction at time of APR was performed in 5 (33%) patients; 2 experienced major wound complications. Overall-survival after salvage APR was 40% (6/15) and disease-free survival was 47% (7/15) at a median follow-up of 14 months (range 2-95 months). Recurrence after salvage-APR occurred in 7 (47%) patients at a median follow-up of 5 months (range 3-19 months). Kaplan-Meier survival analysis showed an advantage for recurrent over persistent disease with 2-year and 5-year survival rates of 75%vs 34% and 28%vs 0%, respectively.
Failure of C-XRT for ECAC is associated with a poor prognosis. Although salvage APR may be curative in some patients, perineal wound complications are frequent and primary flap reconstruction is not reliable.
化疗联合放疗(C-XRT)是肛管表皮样癌(ECAC)的一线治疗方法。高达33%的患者会出现治疗失败。挽救性腹会阴联合切除术(APR)是局部区域失败的首选治疗方法,但术前放疗可能会增加伤口并发症。本研究的目的是评估C-XRT失败后挽救性APR治疗后的患者生存率和伤口并发症。
我们回顾了1992年至2002年间诊断为ECAC且初始C-XRT治疗失败的所有患者的临床记录。我们评估了患者的人口统计学特征、治疗情况、肿瘤特征、生存率和术后并发症。
共确定了19例患者。诊断时的平均年龄为55岁。8例(42%)患者有持续性疾病;11例(58%)有肿瘤复发。15例患者接受了APR手术。12例(80%)患者出现会阴部伤口并发症;其中一半为严重并发症。5例(33%)患者在APR手术时进行了一期皮瓣重建;2例出现严重伤口并发症。挽救性APR后的总生存率为40%(6/15),无病生存率为47%(7/15),中位随访时间为14个月(范围2-95个月)。挽救性APR后复发发生在7例(47%)患者中,中位随访时间为5个月(范围3-19个月)。Kaplan-Meier生存分析显示,复发疾病患者比持续性疾病患者有优势,2年和5年生存率分别为75%对34%和28%对0%。
ECAC的C-XRT治疗失败与预后不良相关。尽管挽救性APR在某些患者中可能治愈,但会阴部伤口并发症频繁,一期皮瓣重建不可靠。